Antonia Borovina, Managing Director, Investment Banking, joined Bloom Burton in 2014. At Bloom Burton, Antonia leads the firm’s advisory team, providing clients with advice on scientific, clinical and capital markets strategy. Her team is also responsible for the firm’s technical and commercial due diligence activities.
Antonia has held several positions at Bloom Burton, most recently as Equity Research Analyst, where she researched publicly traded healthcare companies and made investment recommendations. Prior to joining Bloom Burton, Antonia gained business development experience while working for a direct-to-consumer genetic testing startup.
Antonia currently serves on the Board of Directors and the Commercialization Committee of GlycoNet and is part of the Core Evaluation Team at Genome Canada.
Antonia holds a PhD from the Department of Molecular Genetics at the University of Toronto and a BMSc degree in Biochemistry from Western University.
Antonia Borovina, Managing Director, Investment Banking, joined Bloom Burton in 2014. At Bloom Burton, Antonia leads the firm’s advisory team, providing clients with advice on scientific, clinical and capital markets strategy. Her team is also responsible for the firm’s technical and commercial due diligence activities.
